Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,709 INR | -0.43% | -0.86% | -11.28% |
07/05 | Gland Pharma Gets US FDA's Approval for Generic ALS Drug | MT |
07/05 | Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.28% | 3.39B | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.75% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Jefferies Adjusts Gland Pharma’s Price Target to INR2,400 From INR2,250, Keeps at Buy